CAMBRIDGE, Mass., Oct. 29, 2008 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today provided an update on its pipeline of clinical-stage anti-cancer agents and announced financial results for the third quarter of 2008.
